A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET — Stella

Recruiting

Back to Pancreatic Neuroendocrine Neoplasm trials

Trial locations(1 site)

China

Shanghai General Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Enrollment target

~20 participants

Started

September 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov